Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems
Micro abstractTargeted intraoperative radiotherapy (TARGIT-IORT) is delivered immediately after lumpectomy for breast cancer. We estimated its impact. At least 44,752 patients with breast cancer were treated with TARGIT-IORT in 260 centres in 35 countries, saving >20 million miles of travel a...
Main Authors: | Jayant Sharad Vaidya, Uma Jayant Vaidya, Michael Baum, Max Kishor Bulsara, David Joseph, Jeffrey S. Tobias |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.786515/full |
Similar Items
-
Case Report: Bilateral targeted intraoperative radiotherapy: a safe and effective alternative for synchronous bilateral breast cancer
by: Fardeen Bhimani, et al.
Published: (2023-10-01) -
Case Report: Intraoperative radiotherapy as the new standard of care for breast cancer patients with disabling health conditions or impairments
by: Michael Omosule, et al.
Published: (2023-05-01) -
Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience
by: Andrea Brown, et al.
Published: (2022-06-01) -
Case Report: Can Targeted Intraoperative Radiotherapy in Patients With Breast Cancer and Pacemakers be the New Standard of Care?
by: Fardeen Bhimani, et al.
Published: (2022-07-01) -
Pacemaker and radiotherapy in breast cancer: is targeted intraoperative radiotherapy the answer in this setting?
by: Keshtgar Mohammed RS, et al.
Published: (2012-08-01)